Compound information
- Natural Products
- ZC331129
- Molecular Formula
- C16H18N2O3
- Molecular Weight
- 286.131742436 g/mol
- Structure
-
- IUPAC Name
- benzyl (2S)-2-(prop-2-ynylcarbamoyl)pyrrolidine-1-carboxylate
- InChI
- InChI=1S/C16H18N2O3/c1-2-10-17-15(19)14-9-6-11-18(14)16(20)21-12-13-7-4-3-5-8-13/h1,3-5,7-8,14H,6,9-12H2,(H,17,19)/t14-/m0/s1
- InChI Key
- CENILUCZPMCQHO-AWEZNQCLSA-N
- SMILES
- C#CCNC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1
- Source
- ZINC000089261802
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 58.64 Å2 | LogP | 1.731 |
LogS | -2.105 | LogD | 1.55 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.547 | Pgp substrate | 0.017 |
HIA | 0.963 | F20 % | 0.99 |
F30 % | 0.305 | Caco-2 | -4.896 |
MDCK | -4.69 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.089 | PPB | 86.395 |
VD | 0.49 | Fu | 0.911 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.418 | CYP1A2 substrate | 0.714 |
CYP2A6 substrate | 0.644 | CYP2B6 substrate | 0.618 |
CYP2C19 inhibitor | 0.12 | CYP2C19 substrate | 0.886 |
CYP2C8 substrate | 0.744 | CYP2C9 inhibitor | 0.32 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.015 |
CYP2D6 substrate | 0.952 | CYP2E1 substrate | 0.261 |
CYP3A4 inhibitor | 0.142 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.65 | CL | 4.396 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.877 |
Mutagenicity | 0.034 | Rat Oral Acute Toxicity | 0.182 |
FDAMDD | 0.573 | Skin Sensitization | 0.417 |
Carcinogenicity | 0.122 | Eye Corrosion | 0.003 |
Eye Irritation | 0.13 | Respiratory Toxicity | 0.845 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.205 | IGC50 | 2.615 |
LC50FM | 2.866 | LC50DM | 5.852 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.167 | NR-AR-LBD | 0.212 |
NR-AhR | 0.003 | NR-Aromatase | 0.023 |
NR-ER | 0.21 | NR-ER-LBD | 0.375 |
NR-PPAR-gamma | 0.168 | SR-ARE | 0.1 |
SR-ATAD5 | 0.334 | SR-HSE | 0.115 |
SR-MMP | 0.015 | SR-p53 | 0.015 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.